TORONTO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Nutritional High International Inc. (the “Company”
or “Nutritional High”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) would like to congratulate Aura
Health Inc. (“Aura”) (CSE: BUZZ) for their listing approval and commencement of trading on
Thursday, August, 15th under the symbol “BUZZ”. As a major shareholder in Aura, Nutritional High is pleased to see the
achievement of this major corporate milestone. Aura is engaged in the acquisition and management of marijuana service businesses
and currently holds minority interests in 4 medical marijuana clinics in Arizona, Nevada and Florida. Its long-term goal is to
build an international network of vertically integrated businesses in the medical marijuana field.
Jim Frazier, the CEO of Nutritional High, commented, “This milestone for Aura is a key aspect of their growth
plan and overall corporate strategic vision. Nutritional High has no doubt that Aura will continue to enhance and provide
shareholder value to their current network and future potential investors through continued execution of their business plan and
growth organically and M&A where applicable.”
Chris Carl, President and CEO of Aura, added, “We are very pleased to be listing on the CSE and look forward to
executing our corporate strategy with the greater profile that comes from being publicly traded. Nutritional High has been a key
supporter of Aura and I look forward to a continued strong relationship between the two companies.”
About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing products under recognized brands in
the cannabis products industry, with a specific focus on edibles and oil extracts for medical and adult recreational use. The
Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state
law.
The Company follows a vertically integrated model with a fully developed strategy for acquisitions in
extraction, production, sales, and distribution sectors of the cannabis industry. Nutritional High has brought its flagship FLÏ™
edibles and extracts product line from production to market in California through its wholly owned distributor Calyx Brands Inc.,
and Colorado where its products are manufactured by a licensed producer. The Company also owns a 50% interest in The Clinic
Effingham (an Illinois dispensary), and is entering the Nevada, Washington State, Oregon and Canadian markets in the near
future.
For updates on the Company’s activities and highlights of the Company’s press releases and other media coverage,
please follow Nutritional High on Facebook, Twitter, Instagram and Google+ or visit www.nutritionalhigh.com.
For further information, please contact:
David Posner
Chairman of the Board
Nutritional High International Inc.
647-985-6727
Email: dposner@nutritionalhigh.com
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES
PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release may contain forward-looking statements and information based on current expectations.
These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown
risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from
those implied by such statements. The statements relate to potential market expansion and the use of the proceeds of the
Offering. Risks that may have an impact on the ability for these events to be achieved include completion of due diligence,
negotiation of definitive agreements and receipt of applicable approvals. Although such statements are based on management’s
reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to
update or revise them to reflect new events or circumstances.
The Company’s securities have not been registered under the U.S. Securities Act of 1933, as amended (the
“U.S. Securities Act”), or applicable state securities laws, and may not be offered or sold to, or for the account
or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulation S under the U.S. Securities
Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an
offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any
jurisdiction in which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk factors which could cause the Company’s actual results,
performance or achievements to be materially different from any future results, performance or achievements expressed or implied by
the forward-looking information contained herein. All forward-looking information herein is qualified in its entirety by
this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to
publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results,
events or developments, except as required by law. Some of the risks and other factors that could cause actual results to differ
materially from those expressed in forward-looking information expressed in this press release include, but are not limited to:
obtaining and maintaining regulatory approvals including acquiring and renewing U.S. state, local or other licenses, the
uncertainty of existing protection from U.S. federal or other prosecution, regulatory or political change such as changes in
applicable laws and regulations, including U.S. state-law legalization, market and general economic conditions of the cannabis
sector or otherwise.
